þ | QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Nevada | 52-2088326 | |
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
Page | ||||||||
|
||||||||
1 | ||||||||
1 | ||||||||
3 | ||||||||
4 | ||||||||
12 | ||||||||
14 | ||||||||
41 | ||||||||
54 | ||||||||
|
||||||||
|
||||||||
55 | ||||||||
57 | ||||||||
57 | ||||||||
58 | ||||||||
58 | ||||||||
60 | ||||||||
|
||||||||
61 | ||||||||
|
||||||||
62 | ||||||||
EXHIBIT 10.1
|
||||||||
EXHIBIT 10.2
|
||||||||
EXHIBIT 31.1
|
||||||||
EXHIBIT 31.2
|
||||||||
EXHIBIT 32
|
||||||||
EXHIBIT 10.1 | ||||||||
EXHIBIT 10.2 | ||||||||
EXHIBIT 31.1 | ||||||||
EXHIBIT 31.2 | ||||||||
EXHIBIT 32 |
i
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
(A DEVELOPMENT STAGE ENTERPRISE)
MARCH 31, 2007 (UNAUDITED) AND DECEMBER 31, 2006
March 31, 2007
December 31,
(unaudited)
2006
$
92,336
$
244,228
25,722
21,314
94,143
81,232
212,201
346,774
307,128
322,023
4,500
4,500
$
523,829
$
673,297
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
MARCH 31, 2007 (UNAUDITED) AND DECEMBER 31, 2006
March 31, 2007
December 31,
(unaudited)
2006
$
412,518
$
233,707
473,043
468,413
95,000
95,000
687,526
594,945
660,623
177,926
2,328,710
1,569,991
40,688
40,082
60,000
60,000
30,436,189
29,430,821
(32,341,758
)
(30,427,597
)
(1,804,881
)
(896,694
)
$
523,829
$
673,297
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 AND 2006 AND FOR THE PERIOD
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Cumulative
March 31,
March 31,
since
2007
2006
inception
$
22,000
$
$
52,000
5,360
18,760
16,640
33,240
1,279,775
1,755,438
24,182,751
340,452
57,294
4,545,866
1,610,066
(1,603,587
)
(1,812,732
)
(30,305,443
)
87
212
17
16,268
(207,672
)
(1,184,573
)
(2,963,515
)
(47,104
)
(47,104
)
(42,000
)
(42,000
)
(13,102
)
(13,102
)
1,017,208
(1,913,361
)
(2,997,305
)
(32,337,476
)
800
800
4,282
$
(1,914,161
)
$
(2,998,105
)
$
(32,341,758
)
$
(0.05
)
$
(0.10
)
39,012,446
31,468,333
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Deficit
Total
accumulated
stockholders
Additional
during the
development
Common Stock
Common stock
paid-in
Deferred
development
stage
Shares
Amount
to be issued
capital
compensation
stage
deficiency
$
$
$
$
$
$
10,030,000
10,030
14,270
24,300
(21,307
)
(21,307
)
10,030,000
10,030
14,270
(21,307
)
2,993
198,003
198
516,738
516,936
5,000,000
5,000
5,000
69,122
69
49,444
49,513
(1,075,264
)
(1,075,264
)
15,297,125
15,297
580,452
(1,096,571
)
(500,822
)
20,000
20
20,580
20,600
100,000
100
102,900
103,000
27,000
27
91,233
91,260
50,000
50
168,950
169,000
5,000
5
20,295
20,300
6,000
6
26,634
26,640
1,633
2
7,249
7,251
1,257
1
6,674
6,675
22,000
22
116,798
116,820
9,833
10
52,203
52,213
9,675
9
47,205
47,214
9,833
10
47,975
47,985
35,033
35
74,585
74,620
25,000
25
56,225
56,250
12,833
13
28,861
28,874
9,833
10
14,740
14,750
9,833
10
8,643
8,653
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Deficit
Total
accumulated
stockholders
Additional
during the
development
Common Stock
Common stock
paid-in
Deferred
development
stage
Shares
Amount
to be issued
capital
compensation
stage
deficiency
9,833
10
8,643
8,653
19,082
19
9,522
9,541
5,172
5
2,581
2,586
12,960
13
4,912
4,925
2,000
2
4,258
4,260
(55,000
)
(55
)
(64,245
)
(64,300
)
(1,270,762
)
(1,270,762
)
15,645,935
15,646
1,437,873
(2,367,333
)
(913,814
)
9,833
10
3,038
3,048
9,833
10
3,235
3,245
9,833
10
2,743
2,753
150,000
150
47,850
48,000
9,833
10
2,448
2,458
30,918
31
7,699
7,730
7,040
7
1,753
1,760
132,600
132
33,018
33,150
1,233
1
2,033
2,034
2,678
2
2,274
2,276
150,000
150
92,850
93,000
100,000
100
59,900
60,000
11,111
11
6,655
6,666
400,000
400
379,600
380,000
150,000
150
187,350
187,500
5,000
6
6,745
6,751
1,000,000
1,000
949,000
950,000
20,000
20
16,980
17,000
Table of Contents
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Deficit
accumulated
Total
Additional
during the
stockholders
Common Stock
Common stock
paid-in
Deferred
development
development
Shares
Amount
to be issued
capital
compensation
stage
stage deficiency
43,000
43
42,097
42,140
10,000
10
9,790
9,800
187,000
187
183,073
183,260
2,600,000
(2,600,000
)
142,318
142,318
191,667
191,667
(2,735,013
)
(2,735,013
)
18,085,847
18,086
6,220,322
(2,408,333
)
(5,102,346
)
(1,272,271
)
2,150,000
2,150
857,850
860,000
389,875
389,875
54,909
(54,909
)
891,182
891,182
(2,749,199
)
(2,749,199
)
20,235,847
20,236
389,875
7,133,081
(1,572,060
)
(7,851,545
)
(1,880,413
)
1,425,000
1,425
(213,750
)
212,325
880,000
880
(220,000
)
219,120
670,000
670
166,830
167,500
900,000
900
224,062
224,962
100,000
100
24,900
25,000
1,150,000
1,150
286,330
287,480
475,000
475
118,275
118,750
83,414
83
45,794
45,877
2,000,000
2,000
498,000
500,000
519,000
519
129,231
129,750
1,775,000
1,775
441,976
443,751
1,845,000
1,845
459,405
461,250
1,570,000
1,570
390,930
392,500
500,000
500
124,500
125,000
Table of Contents
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Deficit
accumulated
Total
Additional
during the
stockholders
Common Stock
Common stock
paid-in
Deferred
development
development
Shares
Amount
to be issued
capital
compensation
stage
stage deficiency
43,875
(312,582
)
(268,707
)
6,250
6,250
863,727
863,727
(2,476,063
)
(2,476,063
)
34,128,261
34,128
6,250
10,162,177
(708,333
)
(10,327,608
)
(833,386
)
25,000
25
(6,250
)
6,225
50,000
50
74,950
75,000
82,500
82
12,293
12,375
406,060
407
101,199
101,606
65,000
65
99,385
99,450
60,000
60
91,740
91,800
950,000
950
189,050
190,000
600,000
600
1,019,400
1,020,000
550,000
550
549,450
550,000
4,000
4
1,596
1,600
25,000
25
24,975
25,000
50,000
49
65,451
65,500
20,000
20
24,780
24,800
65,000
65
90,935
91,000
25,000
25
24,975
25,000
150,000
150
149,850
150,000
6,500
6
2,594
2,600
25,000
25
24,975
25,000
172,500
173
172,327
172,500
75,000
75
74,925
75,000
250,000
250
249,750
250,000
(88,384
)
(88,384
)
119,000
119,000
248,891
(248,891
)
Table of Contents
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Deficit
accumulated
Total
Additional
during the
stockholders
Common Stock
Common stock
paid-in
Deferred
development
development
Shares
Amount
to be issued
capital
compensation
stage
stage deficiency
55,381
(55,381
)
1,585,266
1,585,266
28,872
28,872
936,537
936,537
(6,803,280
)
(6,803,280
)
37,784,821
37,784
119,000
15,043,028
(76,068
)
(17,130,888
)
(2,007,144
)
69,000
69
(69,000
)
68,931
50,000
50
(50,000
)
49,950
25,000
25
24,975
25,000
500
1
199
200
325,000
325
324,675
325,000
215,000
215
214,785
215,000
5,000
5
4,995
5,000
300,000
300
299,700
300,000
480,500
480
480,020
480,500
100,000
100
99,900
100,000
80,000
80
79,920
80,000
(8,047,403
)
(8,047
)
8,047
57,092
57,092
555,429
555,429
(109,840
)
(109,840
)
243,750
(243,750
)
31,500
31,500
4,957
4,957
13,505
13,505
177,631
177,631
756,768
756,768
696,413
696,413
(3,115,186
)
(3,115,186
)
Table of Contents
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Deficit
accumulated
Total
Additional
during the
stockholders
Common Stock
Common stock
paid-in
Deferred
development
development
Shares
Amount
to be issued
capital
compensation
stage
stage deficiency
31,387,418
$
31,387
$
612,521
$
18,336,178
$
(142,187
)
$
(20,246,074
)
$
(1,408,175
)
846,549
847
(612,521
)
611,674
25,000
25
37,475
37,500
50,000
50
74,950
75,000
25,000
25
12,475
12,500
10,000
10
9,990
10,000
36,250
36
18,089
18,125
269,600
270
188,450
188,720
473,000
473
737,408
737,881
125,000
125
62,375
62,500
100,000
100
149,900
150,000
35,714
36
24,964
25,000
200,000
200
99,800
100,000
25,000
25
37,475
37,500
50,000
50
24,950
25,000
873,018
872
1,649,136
1,650,008
1,535,716
1,536
1,073,464
1,075,000
900,000
900
449,100
450,000
9,000
9
4,491
4,500
150,000
150
74,850
75,000
15,000
15
22,485
22,500
219,104
219
153,155
153,374
14,603
15
10,207
10,222
1,540,160
1,540
1,076,572
1,078,112
175,000
175
262,325
262,500
50,000
50
74,950
75,000
Table of Contents
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Deficit
accumulated
Total
Additional
during the
stockholders
Common Stock
Common stock
paid-in
Deferred
development
development
Shares
Amount
to be issued
capital
compensation
stage
stage deficiency
14,519
15
14,504
14,519
3,683
4
3,679
3,683
5,000
5
7,495
7,500
4,286
4
2,996
3,000
150,000
150
74,850
75,000
66,654
67
46,591
46,658
210,000
210
104,790
105,000
94,470
94
115,368
115,462
7,300
7
8,349
8,356
27,500
28
22,913
22,941
36,500
36
30,059
30,095
73,863
74
57,244
57,318
18,800
19
10,377
10,396
229,050
229
135,300
135,529
60,000
60,000
2,253,263
2,253,263
401,130
401,130
(142,187
)
142,187
62,497
62,497
408,596
408,596
851,100
851,100
(284,579
)
(284,579
)
(30,402
)
(30,402
)
(10,181,523
)
(10,181,523
)
Table of Contents
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Deficit
accumulated
Total
Additional
during the
stockholders
Common Stock
Common stock
paid-in
Deferred
development
development
Shares
Amount
to be issued
capital
compensation
stage
stage deficiency
40,081,757
$
40,082
$
60,000
$
29,430,821
$
$
(30,427,597
)
$
(896,694
)
63,000
63
39,659
39,722
58,150
58
42,246
42,304
35,800
36
26,009
26,045
162,000
162
112,979
113,141
71,000
71
46,761
46,832
42,600
43
28,056
28,099
92,900
93
62,085
62,178
47,500
48
30,362
30,410
7,500
7
4,722
4,729
25,500
25
15,558
15,583
(32,723
)
(32,723
)
291,936
291,936
274,312
274,312
47,104
47,104
16,302
16,302
(1,914,161
)
(1,914,161
)
40,687,707
40,688
60,000
30,436,189
(32,341,758
)
(1,804,881
)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 AND 2006 AND FOR THE PERIOD
FEBRUARY 18, 1998 (DATE OF INCEPTION) TO MARCH 31, 2007
Cumulative
March 31,
March 31,
since
2007
2006
inception
$
(1,914,161
)
$
(2,998,105
)
$
(32,341,758
)
505,000
(1,017,208
)
63,406
879,619
2,964,990
4,668,102
31,500
4,957
13,102
13,102
1,610,066
204,593
1,133,935
3,003,898
3,060,744
53,832
23,312
242,051
(4,409
)
(25,723
)
(12,911
)
269
(94,143
)
(4,500
)
276,023
25,007
2,508,137
(1,320,525
)
(935,963
)
(14,870,785
)
(38,937
)
(42,141
)
(545,629
)
(38,937
)
(42,141
)
(545,629
)
376,320
726,015
511,450
517,208
850,000
865,500
3,517,878
(18,750
)
(18,750
)
153,127
10,254,949
1,207,570
1,018,627
15,508,750
(151,892
)
40,523
92,336
244,228
279,821
$
92,336
$
320,344
$
92,336
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 AND 2006 AND FOR THE PERIOD FROM
INCEPTION (FEBRUARY 18, 1998) TO MARCH 31, 2007
Cumulative
March 31,
March 31,
since
2007
2006
inception
$
3,079
$
$
144,558
$
800
$
800
$
4,282
$
$
$
505,000
3,202,931
3,550
515,000
113,981
8,047
612,521
45,000
2,580,086
142,187
16,302
16,302
47,104
47,104
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Persuasive evidence of an arrangement exists;
Delivery has Delivery has occurred or services rendered;
The sellers price to the buyer is fixed or determinable; and
Collectibility is reasonably assured.
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Weighted Avg.
Weighted Avg.
Options
Exercise Price
13,250,000
0.11
1,172,652
1.03
14,422,652
0.18
2,085,909
0.92
(10,000,000
)
0.10
6,508,561
0.53
1,313,605
1.21
(2,860,000
)
0.10
(962,607
)
0.84
3,999,559
0.99
20,000
0.85
4,019,559
$
0.99
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Total
Exercisable
Weighted
weighted
weighted
average
average
Average
Exercise
Total options
remaining
exercise
exercise
prices
outstanding
life in years
price
Options exercisable
price
250,000
4.55
0.40
250,000
0.40
2,095,000
8.58
0.85
2,095,000
0.85
650,000
6.16
0.98
650,000
0.98
370,000
8.23
1.00
370,000
1.00
193,912
6.93
1.15
193,912
1.15
310,647
8.90
1.69
310,647
1.69
150,000
3.56
2.26
30,000
2.26
4,019,559
7.56
$
0.99
3,899,559
$
0.95
5.26
4.02
%
188.83
%
0.00
%
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Weighted Avg.
Warrants
Exercise Price
14,252,414
$
0.48
2,372,500
1.27
(960,500
)
0.20
15,664,414
0.62
5,198,574
1.16
(50,500
)
0.99
(20,000
)
1.50
20,792,488
0.75
3,624,894
1.28
(2,328,452
)
0.68
(1,191,619
)
1.46
20,897,311
0.81
1,262,501
0.90
(750,000
)
1.50
21,409,812
0.78
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Year
$
741,000
$
10,000
$
751,000
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
(A DEVELOPMENT STAGE ENTERPRISE)
THREE MONTHS ENDED MARCH 31, 2007 (UNAUDITED)
Table of Contents
revenues and profits;
customers;
research and development expenses and efforts;
scientific and other third-party test results;
sales and marketing expenses and efforts;
liquidity and sufficiency of existing cash;
technology and products;
the outcome of pending or threatened litigation; and
the effect of recent accounting pronouncements on our financial
condition and results of operations.
Table of Contents
Table of Contents
Table of Contents
Gross and net proceeds of $500,000 from the issuance of a convertible note and
related warrants in a private offering to Morale Orchard, LLC (Morale) on January
10, 2007. The face amount of the note is $612,500 and is due on January 9, 2008.
Gross proceeds of $350,000 (net proceeds of $30,000) from the issuance of notes and
related warrants in a private offering (the 2007 PIPE Offering) conducted by Spencer
Clarke, LLC (Spencer Clarke), as exclusive placement agent, that began in January
2007 and was completed on April 27, 2007.
Gross proceeds of $409,043 (net proceeds of $376,320) from the issuance of stock
under our equity line of credit from Dutchess.
Gross proceeds of $50,000 (net proceeds of $44,000) from the issuance of notes and
related warrants in the 2007 PIPE Offering.
Gross proceeds of $583,012 (net proceeds of $536,371) from the issuance of stock
under our equity line of credit from Dutchess.
Gross and net proceeds of $410,000 from the issuance of convertible notes and
related warrants in a private offering (the Spring 2007 Offering).
Table of Contents
Table of Contents
Table of Contents
Year ending December 31,
Operating Leases(1)
Guaranteed Payments
$
149,156
(1)
$
1,585,338
(3)
$
55,680
$
300,000
(4)
$
37,120
(2)
$
75,000
(5)
$
241,956
$
1,960,338
(1)
This amount includes, with respect to the North Hollywood facility: (i)
unpaid base rent from February 2007 through July 2007, in the aggregate amount of
$43,032; (ii) $963 with respect to partially unpaid rent for January 2007; and (iii) a
$100 per day penalty from January 1, 2006 through July 31, 2007, in the aggregate
amount of $57,700, for unpaid rent and/or unpaid late fees claimed by the landlord,
for which the landlord claims we are liable pursuant to a certain provision of the
sublease. We believe that there are numerous reasons why we should not be liable for
most, or all, of any such penalties; however, no assurance can be given that we would
not be liable for any or all of such penalties. We have not renewed the sublease for
our corporate offices at North Hollywood, California, which expires on July 31,
Table of Contents
2007. See Part II, Item 5, Other Information and Notes 13 and 14 to Notes to
Condensed Consolidated Financial Statements, for additional information regarding this
matter. We have assumed that we will renew the lease for our engineering, production
and testing facility at Morgan Hill, California when it expires on August 31, 2007, on
the existing terms, including rent, for an additional two-year period, expiring on July
31, 2009. We currently intend to renew this lease.
(2)
Does not include rent for (i) our corporate offices at North Hollywood,
California beyond July 31, 2007 or (ii) our engineering, production and testing
facility at Morgan Hill, California beyond August 31, 2009, which are the expiration
dates of the respective renewal terms for those two leases.
(3)
Consists of an aggregate $545,600 in total compensation, including base
salary and certain contractually-provided benefits, to two executive officers,
pursuant to employment agreements that expire on December 31, 2007, and to one
additional officer, pursuant to an employment agreement that expires on February 28,
2008; $385,000 in licensing fees to Temple University; $322,800 in severance payments
to a former officer; $240,000 in consulting fees to Spencer Clarke; and $91,938 in
fees to certain other consultants.
(4)
Consists of licensing fees in the amount of $290,000 due to Temple
University; and salary in the amount of $10,000 for two months to an officer, pursuant
to an employment agreement that expires on February 28, 2008. Does not include
compensation to our two executive officers, whose employment agreements expire on
December 31, 2007.
(5)
Consists of licensing fees due to Temple University. Does not include
compensation to our two executive officers, whose employment agreements expire on
December 31, 2007.
Table of Contents
Table of Contents
Table of Contents
Persuasive evidence of an arrangement exists;
Delivery has occurred or services rendered;
The sellers price to the buyer is fixed or determinable; and
Collectibility is reasonably assured.
Cumulative
December 31,
Since
2005
Inception
$
(3,115,186
)
$
(30,427,597
)
(1,039,268
)
(5,010,310
)
177,631
3,060,744
$
(3,976,823
)
$
(32,377,163
)
$
(0.08
)
$
(0.10
)
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Exhibit No.
Description
10.1
10.2
31.1
31.2
32
Table of Contents
SAVE THE WORLD AIR, INC.
Date: July 24, 2007
By:
/s/ CHARLES K. DARGAN II
Charles K. Dargan II
Chief Financial Officer
Table of Contents
Exhibit No.
Description
10.1
10.2
31.1
31.2
32
1
2.1 | No Reduction in Salary . Notwithstanding the provisions of Section 1 above, each component of McKinnons compensation under the Employment Agreement shall remain unchanged for the period commencing the date hereof and continuing thereafter to and including December 31, 2007 (the Remaining Term), which period constitutes the remaining term of the Employment Agreement, all such amounts to be paid in accordance with the Companys normal pay policies applicable to senior officers of the Company; provided, however, that the Company may not declare a moratorium on any payment hereunder to McKinnon as part of cash management by the Company, or any other reason, without McKinnons prior written consent. All compensation under the Employment Agreement that has been accrued but is, as of the date of this Agreement unpaid, as well as all subsequent payments that may become accrued and not paid, shall be paid to McKinnon as soon as reasonably practicable, taking into account the Companys available cash and other operating requirements, but in no event shall such sums be paid later than the first to occur of (i) the consummation of a financing transaction in which at least $2,000,000. gross proceeds are received by the Company and (ii) August 31, 2007 All sums paid hereunder shall be subject to appropriate withholding as required by applicable laws and regulations. | ||
2.2 | Compensation . Pursuant to the Employment Agreement, McKinnon shall remain eligible for and be entitled to any additional amounts, in the form of cash or non-cash compensation, as the Compensation Committee of the Board, or the Board, may determine, in their sole and absolute discretion, or nothing as the Compensation Committee of the Board or the Board may determine. | ||
2.3 | Other Benefits . McKinnon shall be entitled to all other benefits not expressly provided for herein, pursuant to the Employment Agreement for the Remaining Term. |
2
3.5 | Indemnification by McKinnon . McKinnon agrees to indemnify and hold the Company harmless from any Damages which the Company suffers as a result of the agreements made in the Employment Agreement, this Agreement or anything else arising from, or in connection with, McKinnons service as an employee of the Company. | ||
3.6 | 3.6 Statutory Indemnification . Notwithstanding anything to the contrary contained in Sections 3.4 or 3.5 of this Agreement, McKinnon shall be entitled to indemnification in accordance with laws of the state of Nevada, and the Articles of Incorporation and Bylaws of the Company, to the fullest extent provided by law. |
3
4
5
SAVE THE WORLD AIR, INC.
(Company) |
||||||
|
||||||
|
By | |||||
|
||||||
Name: Joseph Helleis | ||||||
Title: Chairman of the Board | ||||||
|
||||||
(McKinnon) | ||||||
|
||||||
Bruce H. McKinnon |
6
1
2
3
4
5
6
7
8
9
10
11
Company
|
/s/ EEE | Executive | /s/ CB | |||||
|
||||||||
|
(initials) | (initials) |
12
13
14
SAVE THE WORLD AIR, INC.
|
||||
By: | /s/ Eugene E. Eichler | |||
EUGENE E. EICHLER | ||||
Title: | Acting Chief Executive Officer | |||
|
||||
EXECUTIVE:
|
||||
/s/ Charles Blum | ||||
CHARLES BLUM | ||||
15
Date: July 24, 2007 | /s/ EUGENE E. EICHLER | |||
Eugene E. Eichler | ||||
Acting Chief Executive Officer | ||||
Date: July 24, 2007 | /s/ CHARLES K. DARGAN II | |||
Charles K. Dargan II | ||||
Chief Financial Officer |
Date: July 24, 2007 | /s/ EUGENE E. EICHLER | |||
Eugene E. Eichler | ||||
Acting Chief Executive Officer | ||||
Date: July 24, 2007 | /s/ CHARLES K. DARGAN II | |||
Charles K. Dargan II | ||||
Chief Financial Officer | ||||